Our goal is to describe our experience in the difficulties encountered during radical
cystectomy for muscle invasive bladder cancer in patients with contemporary pelvic
kidney. Two patients with muscle invasive bladder cancer and contemporary pelvic
kidney were subjected to radical cystectomy and extended lymphadenectomy with
conversion to an ileal pouch. In both cases, lymphadenectomy was the first step after
entering the true pelvis. In order to proceed to the cystoprostatectomy, careful
dissection of the ectopic renal vessels and proper mobilization of the kidney were
performed. In both cases, an ileal pouch was our choice. The pelvic kidney is the most
common sight of renal ectopia. The etiology is the aborted ascent of the fetal kidney
from its initial position in the pelvis. This is the first case series describing radical
cystectomy for muscle invasive urothelial carcinoma of the bladder in patients with a
pelvic kidney.
Bladder cancer constitutes the ninth most common cancer worldwide and approximately only 30% of cases are muscle invasive at initial diagnosis. Regional lymph nodes, bones, lung, and liver are the most common metastases from bladder cancer and generally from genitourinary malignancies. Muscles constitute a rare site of metastases from distant primary lesions even though they represent 50% of total body mass and receive a large blood flow. Skeletal muscles from urothelial carcinoma are very rare and up to date only few cases have been reported in the literature. We present a rare case of 51-year-old patient with metastases to sartorius muscle 8 months after the radical cystectomy performed for a muscle invasive bladder cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.